ARCA biopharma competitors

ARCA biopharma Competitors include Vical, Ultragenyx Pharmaceutical, Illumina and Orphazyme.
Add company...
ARCA biopharma
ARCA biopharma develops genetically-targeted therapies for cardiovascular diseases.
Vical
Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Illumina
Illumina is a global company that develops innovative array-based solutions for DNA, RNA, and protein analysis.
Orphazyme
Orphazyme develops therapies for the treatment of a family of serious genetic disorders called lysosomal storage diseases.
Founding Date
Founding Date
2009
Founding Date
1987
Founding Date
2010
Founding Date
1998
Founding Date
2009
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Westminster, US HQ
Aurora, US
Westminster, US
Locations
San Diego, US HQ
Locations
Novato, US HQ
Locations
San Diego, US HQ
Scoresby, AU
São Paulo, BR
Victoria, CA
Shanghai, CN
Beijing, CN
Minato, JP
see more
Locations
København, DK HQ
Newton, US
Employees
Employees
20
Employees
73
Employees
376
Employees
6,20013% increase
Employees
34
Valuation ($)
Valuation ($)
8.8 m
Valuation ($)
27.3 m
Valuation ($)
3.2 b
Valuation ($)
47.3 b
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
65
Twitter followers
N/A
Twitter followers
57 k
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$13.8m (FY, 2017)
Revenue (est.)
$133k (FY, 2016)
Revenue (est.)
$2.4b (FY, 2017)
Revenue (est.)
N/A
Net income
Net income
($18.5m) (FY, 2017)
Net income
($13m) (FY, 2017)
Net income
($245.9m) (FY, 2016)
Net income
$428.1m (FY, 2017)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 7.2m
Total funding raised
N/A
Total funding raised
$ 200.1m
Total funding raised
N/A
Total funding raised
$ 58.8m
For sources of this data, please see the company profileDownload Excel

View company profiles

Vical
HQ
San Diego, US
Employees
73

Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies.

View company
Ultragenyx Pharmaceutical
HQ
Novato, US
Employees
376

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

View company
Illumina
HQ
San Diego, US
Employees
6,200↑ 13% increase

Illumina is a global company that develops innovative array-based solutions for DNA, RNA, and protein analysis.

View company
Orphazyme
HQ
København, DK
Employees
34

Orphazyme develops therapies for the treatment of a family of serious genetic disorders called lysosomal storage diseases.

View company